Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchopulmonary Dysplasia | 13 | 2022 | 314 | 2.810 |
Why?
|
Neonatal Screening | 29 | 2024 | 595 | 2.740 |
Why?
|
Cystic Fibrosis | 29 | 2022 | 1274 | 2.560 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 16 | 2019 | 446 | 1.520 |
Why?
|
Uteroglobin | 2 | 2022 | 56 | 1.470 |
Why?
|
Genetic Counseling | 6 | 2022 | 625 | 1.230 |
Why?
|
Respiratory Distress Syndrome, Newborn | 6 | 2019 | 227 | 1.050 |
Why?
|
Infant, Newborn | 73 | 2024 | 26168 | 0.910 |
Why?
|
Genetic Testing | 18 | 2023 | 3530 | 0.750 |
Why?
|
Infant, Premature, Diseases | 9 | 2019 | 708 | 0.720 |
Why?
|
Infant, Premature | 11 | 2021 | 2091 | 0.700 |
Why?
|
Insurance | 1 | 2021 | 114 | 0.670 |
Why?
|
Twin Studies as Topic | 1 | 2018 | 104 | 0.630 |
Why?
|
Dinucleotide Repeats | 1 | 2016 | 29 | 0.550 |
Why?
|
Gestational Age | 13 | 2022 | 3564 | 0.550 |
Why?
|
Superoxide Dismutase | 5 | 2012 | 594 | 0.510 |
Why?
|
Lung Diseases | 4 | 2019 | 1915 | 0.500 |
Why?
|
Sweat | 6 | 2011 | 56 | 0.470 |
Why?
|
Trypsinogen | 6 | 2011 | 84 | 0.470 |
Why?
|
Neurotoxicity Syndromes | 1 | 2018 | 299 | 0.460 |
Why?
|
Enterocolitis, Necrotizing | 3 | 2021 | 326 | 0.420 |
Why?
|
Anesthetics | 1 | 2018 | 522 | 0.410 |
Why?
|
Neonatology | 1 | 2014 | 140 | 0.400 |
Why?
|
Chlorides | 6 | 2011 | 666 | 0.390 |
Why?
|
Fetus | 2 | 2018 | 1859 | 0.380 |
Why?
|
DNA Mutational Analysis | 9 | 2011 | 4109 | 0.380 |
Why?
|
Retinopathy of Prematurity | 2 | 2013 | 432 | 0.370 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2012 | 404 | 0.360 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 600 | 0.350 |
Why?
|
Epithelial Cells | 1 | 2022 | 3665 | 0.350 |
Why?
|
Hypnotics and Sedatives | 1 | 2018 | 1178 | 0.340 |
Why?
|
High-Frequency Ventilation | 1 | 2010 | 88 | 0.340 |
Why?
|
Parents | 7 | 2022 | 3547 | 0.330 |
Why?
|
Pseudomonas Infections | 2 | 2006 | 623 | 0.320 |
Why?
|
Cause of Death | 1 | 2018 | 3723 | 0.300 |
Why?
|
Respiration, Artificial | 7 | 2013 | 2623 | 0.290 |
Why?
|
Infant | 18 | 2024 | 36030 | 0.260 |
Why?
|
Iontophoresis | 1 | 2005 | 74 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 17766 | 0.240 |
Why?
|
Ultrasonography, Prenatal | 8 | 2013 | 1745 | 0.240 |
Why?
|
Antioxidants | 1 | 2012 | 1668 | 0.230 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3526 | 0.220 |
Why?
|
Immunoassay | 2 | 2010 | 748 | 0.210 |
Why?
|
Fetal Diseases | 6 | 2019 | 911 | 0.210 |
Why?
|
Pulmonary Surfactants | 4 | 2019 | 161 | 0.200 |
Why?
|
Genomics | 5 | 2023 | 5790 | 0.200 |
Why?
|
Internet | 1 | 2014 | 3074 | 0.200 |
Why?
|
Clubfoot | 2 | 2013 | 87 | 0.190 |
Why?
|
Child Development | 5 | 2012 | 2280 | 0.180 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2024 | 268 | 0.180 |
Why?
|
Humans | 91 | 2024 | 760261 | 0.180 |
Why?
|
Attitude of Health Personnel | 2 | 2014 | 3870 | 0.180 |
Why?
|
Body Fluids | 1 | 2022 | 319 | 0.170 |
Why?
|
Genome, Human | 3 | 2023 | 4416 | 0.160 |
Why?
|
Infant Care | 2 | 2012 | 180 | 0.160 |
Why?
|
Infant, Newborn, Diseases | 2 | 2021 | 592 | 0.160 |
Why?
|
False Positive Reactions | 5 | 2013 | 956 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
Recombinant Proteins | 6 | 2019 | 6543 | 0.160 |
Why?
|
Sequence Analysis, DNA | 3 | 2019 | 4717 | 0.160 |
Why?
|
Endotoxins | 2 | 2012 | 521 | 0.160 |
Why?
|
Intensive Care, Neonatal | 2 | 2010 | 197 | 0.150 |
Why?
|
Twins, Dizygotic | 1 | 2018 | 236 | 0.150 |
Why?
|
Intestinal Atresia | 2 | 1995 | 69 | 0.150 |
Why?
|
Fetal Growth Retardation | 2 | 2012 | 579 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2021 | 3483 | 0.140 |
Why?
|
Twins, Monozygotic | 1 | 2018 | 469 | 0.140 |
Why?
|
Radiography, Abdominal | 1 | 2020 | 532 | 0.140 |
Why?
|
Complement C1 Inactivator Proteins | 3 | 1992 | 92 | 0.130 |
Why?
|
Trachea | 3 | 2012 | 1082 | 0.130 |
Why?
|
Health | 1 | 2019 | 395 | 0.130 |
Why?
|
International Classification of Diseases | 1 | 2021 | 884 | 0.130 |
Why?
|
Mouth | 1 | 1998 | 380 | 0.130 |
Why?
|
Echo-Planar Imaging | 1 | 2019 | 657 | 0.120 |
Why?
|
Angioedema | 3 | 1992 | 192 | 0.120 |
Why?
|
California | 2 | 2016 | 1416 | 0.120 |
Why?
|
Ultrasonography | 5 | 2021 | 5960 | 0.120 |
Why?
|
False Negative Reactions | 2 | 2005 | 574 | 0.120 |
Why?
|
Algorithms | 7 | 2014 | 13967 | 0.120 |
Why?
|
Internship and Residency | 1 | 2014 | 5867 | 0.110 |
Why?
|
Female | 41 | 2024 | 391011 | 0.110 |
Why?
|
Boston | 2 | 2018 | 9282 | 0.110 |
Why?
|
Decision Trees | 2 | 2005 | 506 | 0.110 |
Why?
|
Ileum | 2 | 1999 | 556 | 0.110 |
Why?
|
Disease | 1 | 2019 | 671 | 0.110 |
Why?
|
Risk Factors | 11 | 2021 | 74269 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3618 | 0.110 |
Why?
|
Lung | 6 | 2019 | 9989 | 0.110 |
Why?
|
Infant, Very Low Birth Weight | 4 | 2009 | 406 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2021 | 80301 | 0.100 |
Why?
|
Respiration | 1 | 2019 | 1648 | 0.100 |
Why?
|
Mutation | 9 | 2017 | 29950 | 0.100 |
Why?
|
Genetic Diseases, Inborn | 1 | 2017 | 601 | 0.100 |
Why?
|
Male | 32 | 2024 | 359413 | 0.100 |
Why?
|
Double-Blind Method | 2 | 2019 | 12412 | 0.100 |
Why?
|
S100 Proteins | 1 | 2012 | 218 | 0.100 |
Why?
|
Homozygote | 1 | 1996 | 1786 | 0.100 |
Why?
|
Pregnancy | 12 | 2018 | 29725 | 0.100 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 362 | 0.090 |
Why?
|
Intestinal Obstruction | 1 | 1995 | 435 | 0.090 |
Why?
|
Soy Foods | 1 | 2010 | 44 | 0.090 |
Why?
|
Phytoestrogens | 1 | 2010 | 59 | 0.090 |
Why?
|
Massachusetts | 8 | 2010 | 8805 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3159 | 0.090 |
Why?
|
Respiratory Function Tests | 1 | 2015 | 1684 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1799 | 0.080 |
Why?
|
Reference Values | 5 | 2009 | 4920 | 0.080 |
Why?
|
Prenatal Diagnosis | 1 | 2016 | 1262 | 0.080 |
Why?
|
Ethics, Medical | 1 | 2014 | 787 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2012 | 3046 | 0.080 |
Why?
|
Chromosome Deletion | 2 | 1990 | 1387 | 0.080 |
Why?
|
Oropharynx | 1 | 2009 | 132 | 0.080 |
Why?
|
Foundations | 1 | 2008 | 97 | 0.080 |
Why?
|
Decision Making, Organizational | 2 | 2005 | 136 | 0.080 |
Why?
|
Alleles | 2 | 2016 | 6900 | 0.070 |
Why?
|
Testis | 1 | 2010 | 794 | 0.070 |
Why?
|
Parenting | 2 | 2022 | 695 | 0.070 |
Why?
|
Ventilators, Mechanical | 1 | 2009 | 287 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3568 | 0.070 |
Why?
|
Risk Assessment | 5 | 2021 | 24086 | 0.070 |
Why?
|
Genotype | 6 | 2014 | 12959 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2716 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2709 | 0.070 |
Why?
|
Uterus | 1 | 2010 | 651 | 0.070 |
Why?
|
Heart Defects, Congenital | 2 | 2021 | 4668 | 0.070 |
Why?
|
Ovary | 1 | 2010 | 959 | 0.070 |
Why?
|
Age of Onset | 2 | 2019 | 3302 | 0.070 |
Why?
|
Chronic Disease | 3 | 2019 | 9283 | 0.070 |
Why?
|
Lysine | 1 | 1990 | 1002 | 0.060 |
Why?
|
Pilocarpine | 1 | 2005 | 64 | 0.060 |
Why?
|
Point Mutation | 2 | 2006 | 1594 | 0.060 |
Why?
|
Death | 1 | 2010 | 678 | 0.060 |
Why?
|
Histidine | 1 | 2006 | 311 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1118 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2383 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 2 | 2006 | 1275 | 0.060 |
Why?
|
Carrier State | 1 | 2009 | 525 | 0.060 |
Why?
|
Muscarinic Agonists | 1 | 2005 | 91 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 1992 | 1023 | 0.060 |
Why?
|
Logistic Models | 4 | 2021 | 13311 | 0.060 |
Why?
|
Data Collection | 1 | 2014 | 3317 | 0.060 |
Why?
|
Survival Rate | 2 | 2018 | 12806 | 0.060 |
Why?
|
Phenotype | 3 | 2019 | 16543 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3327 | 0.060 |
Why?
|
Cohort Studies | 2 | 2018 | 41317 | 0.060 |
Why?
|
Oxygen | 2 | 1992 | 4189 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2009 | 909 | 0.060 |
Why?
|
Estrogens | 1 | 2010 | 1520 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4763 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2655 | 0.060 |
Why?
|
Program Development | 2 | 2010 | 1297 | 0.050 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15273 | 0.050 |
Why?
|
Metabolic Diseases | 1 | 2009 | 685 | 0.050 |
Why?
|
Program Evaluation | 5 | 2010 | 2494 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 8018 | 0.050 |
Why?
|
Arginine | 1 | 2006 | 934 | 0.050 |
Why?
|
Hospital Costs | 1 | 2009 | 976 | 0.050 |
Why?
|
Needs Assessment | 2 | 2005 | 1137 | 0.050 |
Why?
|
Bombesin | 1 | 2002 | 35 | 0.050 |
Why?
|
Prostate | 1 | 2010 | 1793 | 0.050 |
Why?
|
Base Sequence | 7 | 2017 | 12447 | 0.050 |
Why?
|
Tissue and Organ Procurement | 1 | 2010 | 944 | 0.050 |
Why?
|
Free Radical Scavengers | 1 | 2003 | 211 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5396 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 64947 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15687 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4625 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2005 | 1181 | 0.040 |
Why?
|
Age Factors | 5 | 2012 | 18415 | 0.040 |
Why?
|
Child, Preschool | 3 | 2024 | 42034 | 0.040 |
Why?
|
Patient Selection | 2 | 2018 | 4276 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2013 | 15827 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2020 | 14482 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2021 | 166 | 0.040 |
Why?
|
Erythema | 1 | 2021 | 262 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2005 | 1439 | 0.040 |
Why?
|
Sensitivity and Specificity | 6 | 2016 | 14656 | 0.040 |
Why?
|
Follow-Up Studies | 6 | 2010 | 39254 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3840 | 0.040 |
Why?
|
Primary Health Care | 3 | 2010 | 4649 | 0.040 |
Why?
|
Membrane Proteins | 2 | 1993 | 7854 | 0.040 |
Why?
|
Child Health Services | 1 | 2003 | 644 | 0.040 |
Why?
|
Attitude to Health | 3 | 2018 | 2028 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13300 | 0.040 |
Why?
|
Pilot Projects | 4 | 2021 | 8553 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1679 | 0.040 |
Why?
|
Heterozygote | 3 | 2019 | 2797 | 0.040 |
Why?
|
Radiography | 2 | 2021 | 6965 | 0.040 |
Why?
|
Exons | 2 | 1996 | 2391 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2006 | 2563 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8641 | 0.040 |
Why?
|
Brain | 3 | 2019 | 26912 | 0.040 |
Why?
|
Incidence | 2 | 2012 | 21378 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1635 | 0.030 |
Why?
|
Parent-Child Relations | 1 | 2021 | 759 | 0.030 |
Why?
|
Infant, Low Birth Weight | 2 | 2000 | 858 | 0.030 |
Why?
|
Genomic Structural Variation | 1 | 2017 | 63 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20048 | 0.030 |
Why?
|
Telephone | 1 | 2020 | 623 | 0.030 |
Why?
|
Time Factors | 6 | 2012 | 40133 | 0.030 |
Why?
|
Hyaline Membrane Disease | 2 | 1987 | 19 | 0.030 |
Why?
|
Genetic Research | 1 | 2017 | 172 | 0.030 |
Why?
|
Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 1995 | 41 | 0.030 |
Why?
|
Genetic Variation | 3 | 2019 | 6540 | 0.030 |
Why?
|
Dandy-Walker Syndrome | 1 | 1995 | 45 | 0.030 |
Why?
|
Bronchopulmonary Sequestration | 1 | 1995 | 43 | 0.030 |
Why?
|
Adult | 12 | 2022 | 219847 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 5876 | 0.030 |
Why?
|
Health Status | 2 | 2009 | 4081 | 0.030 |
Why?
|
Arachnoid Cysts | 1 | 1995 | 61 | 0.030 |
Why?
|
Abdomen | 1 | 2021 | 1124 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2005 | 3598 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2012 | 6242 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1870 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2019 | 680 | 0.030 |
Why?
|
Duodenal Obstruction | 1 | 1994 | 25 | 0.030 |
Why?
|
RNA, Messenger | 3 | 1999 | 12762 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7468 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 1999 | 1810 | 0.030 |
Why?
|
Diffusion | 1 | 2016 | 814 | 0.030 |
Why?
|
Alternative Splicing | 1 | 1999 | 1091 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2017 | 833 | 0.030 |
Why?
|
RNA Splicing | 1 | 2018 | 914 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 1999 | 1470 | 0.030 |
Why?
|
United States | 3 | 2017 | 72363 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 1993 | 17628 | 0.030 |
Why?
|
Limulus Test | 1 | 2012 | 19 | 0.030 |
Why?
|
Health Policy | 1 | 2005 | 2678 | 0.030 |
Why?
|
Motivation | 1 | 2022 | 1990 | 0.030 |
Why?
|
Decision Making | 2 | 2022 | 3924 | 0.030 |
Why?
|
Tracheoesophageal Fistula | 1 | 1994 | 131 | 0.030 |
Why?
|
Feasibility Studies | 3 | 2016 | 5201 | 0.030 |
Why?
|
Family | 2 | 2018 | 3189 | 0.030 |
Why?
|
Models, Organizational | 2 | 2005 | 545 | 0.020 |
Why?
|
Informed Consent | 1 | 2018 | 1007 | 0.020 |
Why?
|
Proteome | 1 | 2022 | 1856 | 0.020 |
Why?
|
Introns | 2 | 1992 | 978 | 0.020 |
Why?
|
Caregivers | 1 | 2003 | 2222 | 0.020 |
Why?
|
Prospective Studies | 7 | 2019 | 54263 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2001 | 2143 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 1995 | 983 | 0.020 |
Why?
|
Embryonic and Fetal Development | 1 | 1992 | 420 | 0.020 |
Why?
|
Esophageal Atresia | 1 | 1994 | 216 | 0.020 |
Why?
|
Communication | 1 | 2005 | 3846 | 0.020 |
Why?
|
Fetal Heart | 1 | 1992 | 281 | 0.020 |
Why?
|
Mouth Mucosa | 1 | 1993 | 426 | 0.020 |
Why?
|
Cell-Free System | 1 | 1990 | 341 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1739 | 0.020 |
Why?
|
Gram-Negative Aerobic Rods and Cocci | 1 | 2009 | 1 | 0.020 |
Why?
|
Basal Ganglia | 1 | 1992 | 552 | 0.020 |
Why?
|
Gram-Positive Cocci | 1 | 2009 | 8 | 0.020 |
Why?
|
DNA | 3 | 2011 | 7236 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2009 | 22041 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2363 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 851 | 0.020 |
Why?
|
Pancreas | 1 | 1996 | 1677 | 0.020 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 1989 | 80 | 0.020 |
Why?
|
Aftercare | 2 | 2005 | 918 | 0.020 |
Why?
|
Infant Formula | 1 | 2010 | 193 | 0.020 |
Why?
|
Neuropsychology | 1 | 2009 | 107 | 0.020 |
Why?
|
Neurophysiology | 1 | 2009 | 144 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3810 | 0.020 |
Why?
|
Nutritional Requirements | 1 | 2009 | 275 | 0.020 |
Why?
|
Molecular Weight | 1 | 1990 | 2186 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1975 | 1297 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1746 | 0.020 |
Why?
|
Milk | 1 | 2010 | 443 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2776 | 0.020 |
Why?
|
Cattle | 2 | 2010 | 3847 | 0.020 |
Why?
|
Endocrine Disruptors | 1 | 2010 | 263 | 0.020 |
Why?
|
Glycosylation | 1 | 1990 | 1097 | 0.020 |
Why?
|
Child | 3 | 2022 | 79758 | 0.020 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2009 | 355 | 0.020 |
Why?
|
Standard of Care | 1 | 2010 | 552 | 0.020 |
Why?
|
Thalamus | 1 | 1992 | 1041 | 0.020 |
Why?
|
Milk, Human | 1 | 2010 | 484 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 1992 | 831 | 0.020 |
Why?
|
Placebos | 2 | 2003 | 1672 | 0.020 |
Why?
|
Mandatory Testing | 1 | 2005 | 23 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2009 | 580 | 0.020 |
Why?
|
Anthropometry | 1 | 2010 | 1348 | 0.020 |
Why?
|
Image Enhancement | 1 | 2016 | 2877 | 0.020 |
Why?
|
Parental Consent | 1 | 2005 | 63 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2651 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3257 | 0.020 |
Why?
|
Physician Executives | 1 | 2005 | 133 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2010 | 25928 | 0.010 |
Why?
|
Cost-Benefit Analysis | 2 | 2009 | 5507 | 0.010 |
Why?
|
Pregnancy Outcome | 2 | 2010 | 2906 | 0.010 |
Why?
|
Blood Proteins | 1 | 2009 | 1172 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 6067 | 0.010 |
Why?
|
Cost Savings | 1 | 2009 | 920 | 0.010 |
Why?
|
Syndrome | 1 | 2009 | 3278 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3335 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2932 | 0.010 |
Why?
|
Intestines | 1 | 1992 | 1907 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1990 | 2104 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10829 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2009 | 1828 | 0.010 |
Why?
|
Computational Biology | 1 | 2014 | 3504 | 0.010 |
Why?
|
Intubation, Intratracheal | 2 | 2003 | 1328 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1992 | 13456 | 0.010 |
Why?
|
Health Care Rationing | 1 | 2005 | 435 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1876 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2009 | 982 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5873 | 0.010 |
Why?
|
Policy Making | 1 | 2005 | 539 | 0.010 |
Why?
|
Developmental Disabilities | 1 | 2010 | 1504 | 0.010 |
Why?
|
Models, Psychological | 1 | 2005 | 826 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1992 | 4286 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6361 | 0.010 |
Why?
|
Homeostasis | 1 | 1992 | 3305 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4900 | 0.010 |
Why?
|
Electrolytes | 1 | 2001 | 280 | 0.010 |
Why?
|
Sweating | 1 | 2001 | 154 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2005 | 3967 | 0.010 |
Why?
|
Drug Costs | 1 | 2009 | 1184 | 0.010 |
Why?
|
Barotrauma | 1 | 2000 | 39 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 1822 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2001 | 642 | 0.010 |
Why?
|
Echocardiography | 1 | 1992 | 4980 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2000 | 186 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10530 | 0.010 |
Why?
|
Sepsis | 1 | 2013 | 2594 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1650 | 0.010 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 1989 | 1455 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2696 | 0.010 |
Why?
|
Pulmonary Alveoli | 2 | 1984 | 653 | 0.010 |
Why?
|
New York | 1 | 2000 | 874 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12602 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7345 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 7016 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2000 | 1156 | 0.010 |
Why?
|
Nutritional Status | 1 | 2005 | 1606 | 0.010 |
Why?
|
Electroencephalography | 1 | 2012 | 6182 | 0.010 |
Why?
|
Esophageal Cyst | 1 | 1995 | 13 | 0.010 |
Why?
|
Polyhydramnios | 1 | 1995 | 41 | 0.010 |
Why?
|
Social Support | 1 | 2005 | 2145 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2000 | 1526 | 0.010 |
Why?
|
Atmosphere Exposure Chambers | 1 | 1975 | 51 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2009 | 10340 | 0.010 |
Why?
|
Mediastinal Diseases | 1 | 1995 | 91 | 0.010 |
Why?
|
Cranial Fossa, Posterior | 1 | 1995 | 135 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2005 | 2628 | 0.010 |
Why?
|
Air | 1 | 1975 | 186 | 0.010 |
Why?
|
Animals | 6 | 2010 | 167940 | 0.010 |
Why?
|
Karyotyping | 1 | 1995 | 1172 | 0.010 |
Why?
|
Amniotic Fluid | 1 | 1995 | 378 | 0.010 |
Why?
|
Thoracic Neoplasms | 1 | 1995 | 265 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 3696 | 0.010 |
Why?
|
Antilymphocyte Serum | 1 | 1975 | 482 | 0.010 |
Why?
|
Cheek | 1 | 1993 | 65 | 0.010 |
Why?
|
Complement C1s | 1 | 1992 | 11 | 0.010 |
Why?
|
Safety | 1 | 1997 | 1149 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4573 | 0.010 |
Why?
|
Threonine | 1 | 1992 | 272 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1994 | 732 | 0.010 |
Why?
|
Glutamates | 1 | 1992 | 391 | 0.010 |
Why?
|
Colon | 1 | 1999 | 1788 | 0.010 |
Why?
|
Adolescent | 1 | 1999 | 87747 | 0.010 |
Why?
|
Kallikreins | 1 | 1992 | 231 | 0.010 |
Why?
|
Valine | 1 | 1992 | 409 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 1992 | 527 | 0.010 |
Why?
|
Abortion, Spontaneous | 1 | 1995 | 530 | 0.010 |
Why?
|
Codon | 1 | 1992 | 602 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1992 | 463 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2003 | 12156 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3804 | 0.010 |
Why?
|
Taq Polymerase | 1 | 1989 | 20 | 0.010 |
Why?
|
Alanine | 1 | 1992 | 607 | 0.010 |
Why?
|
Blotting, Western | 1 | 1997 | 5039 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1992 | 1230 | 0.010 |
Why?
|
Antibodies | 1 | 1997 | 2424 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1993 | 1577 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1989 | 778 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 36247 | 0.000 |
Why?
|
Specimen Handling | 1 | 1993 | 708 | 0.000 |
Why?
|
Blotting, Northern | 1 | 1989 | 1544 | 0.000 |
Why?
|
Neuroblastoma | 1 | 1995 | 1252 | 0.000 |
Why?
|
Respiratory Insufficiency | 1 | 1995 | 1228 | 0.000 |
Why?
|
Aged | 1 | 2019 | 168995 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 58673 | 0.000 |
Why?
|
Glutamic Acid | 1 | 1992 | 1166 | 0.000 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 1989 | 491 | 0.000 |
Why?
|
Chromosome Aberrations | 1 | 1992 | 1767 | 0.000 |
Why?
|
Pulmonary Gas Exchange | 1 | 1987 | 378 | 0.000 |
Why?
|
Phosphatidylglycerols | 1 | 1984 | 34 | 0.000 |
Why?
|
Gene Amplification | 1 | 1989 | 1085 | 0.000 |
Why?
|
Transfection | 1 | 1992 | 5782 | 0.000 |
Why?
|
Brain Diseases | 1 | 1992 | 1540 | 0.000 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1984 | 218 | 0.000 |
Why?
|
Random Allocation | 1 | 1987 | 2394 | 0.000 |
Why?
|
Fibroblasts | 1 | 1992 | 4091 | 0.000 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1992 | 2127 | 0.000 |
Why?
|
Clinical Trials as Topic | 2 | 1987 | 8058 | 0.000 |
Why?
|
Prognosis | 1 | 2000 | 29636 | 0.000 |
Why?
|
Cell Line | 1 | 1992 | 15626 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1992 | 18968 | 0.000 |
Why?
|
Mice | 1 | 1975 | 81216 | 0.000 |
Why?
|